Key Takeaways
- Q1 2026 revenue hit an all-time high of $1.282 billion, representing 87% growth from the prior year
- Earnings per share of $2.56 exceeded analyst predictions by 23%, marking 241% annual growth
- Shares plummeted approximately 15% as traders zeroed in on forward-looking projections
- Artificial intelligence applications generated roughly 70% of quarterly sales; gross profitability reached unprecedented 60.9%
- Second quarter projections calling for $1.20B in sales and $2.00 EPS barely cleared Street expectations
Teradyne delivered what appeared to be flawless quarterly performance. Historic sales figures, unprecedented profitability margins, earnings that demolished analyst forecasts by more than 23%. Wall Street’s verdict? A brutal 15% selloff.
The disconnect between achievement and market sentiment reveals everything investors need to understand about this situation.
First quarter 2026 sales reached $1.282 billion, climbing 87% annually and surpassing the $1.19 billion analyst consensus. Earnings per share of $2.56 demolished the $2.08 projection by a substantial amount. Gross profitability climbed to 60.9%, establishing a new company benchmark. Operating profit touched $480 million, translating to a 37.5% margin.
The company’s Semiconductor Test division eclipsed one billion dollars in quarterly sales for its inaugural time. Artificial intelligence-driven business represented approximately 70% of overall sales, establishing itself as the undeniable catalyst powering expansion.
Yet despite these achievements, shares declined 12.91% during after-hours activity Tuesday, then extended declines toward 18% in premarket Wednesday trading before stabilizing around a 15% decrease during normal market hours.
Forward Projections Disappointed Bullish Expectations
The problem wasn’t the company’s recent performance. The concern centered on what management expects ahead.
Teradyne issued second quarter projections calling for approximately $1.20 billion in sales and roughly $2.00 in earnings per share at the midpoint. These figures landed marginally above analyst forecasts — falling short of the commanding beat traders anticipated following an outstanding quarter.
Profitability margin projections also generated concern. The projected Q2 gross margin around 57.5% would mark a sequential decline of approximately 350 basis points from the first quarter’s historic performance. UBS researchers characterized this as “somewhat unusual unless external factors are influencing results,” while simultaneously dismissing speculation about Apple-related impacts given that revenue projections weren’t substantially elevated.
Premium Valuation Demands Perfection
Teradyne commands a P/E multiple of 109.78 alongside a PEG ratio of 23.77. These represent elevated metrics under any assessment framework, leaving minimal tolerance for anything less than impeccable performance and forward guidance.
InvestingPro identified the shares as trading above its Fair Value calculation prior to the earnings announcement.
Notwithstanding the sharp decline, UBS maintained its Buy recommendation alongside a $440 price objective. Research analyst Timothy Arcuri encouraged market participants to “step back and consider the broader context,” contending that increasing test complexity throughout the semiconductor ecosystem should substantially expand the addressable market opportunity for semiconductor testing in subsequent years.
Arcuri additionally challenged the market share fixation that frequently dominates analysis of Teradyne, characterizing it as “likely excessively narrow-focused” considering the widening revenue opportunity across the semiconductor landscape more broadly.
Chief Executive Mark Jagiela highlighted sustained artificial intelligence and data center appetite as the organization’s primary growth catalyst. “We sit at the epicenter of the AI revolution, and our performance demonstrates the extraordinary demand for AI-powered data center infrastructure,” he stated during the analyst conference.
Teradyne’s 52-week peak sits at $422.11. Shares traded near $325 Wednesday, significantly below that summit.


